Has the 23-day lockout requirement been eliminated for Female Patients of Childbearing Potential?
Yes. The 23-day lockout period has been eliminated for female patients of childbearing potential. Previously, whether a prescription was filled or not, a female patient of childbearing potential could not start the qualification process for another prescription until 23 days after the end of her 7-day prescription window. While the prescribing procedures and qualification criteria for isotretinoin will remain the same, the elimination of the 23-day lockout period will allow female patients of childbearing potential the ability to re-qualify and have a new prescription filled immediately after the 7-day prescription window has expired. NOTE: However, female patients of childbearing potential (FCBP) that do not fill and pick up the FIRST prescription of their therapy before their 7-day prescription window expires will be locked out of the system for at least 19 days. The call center cannot authorize exceptions to the lockout period. For example, an FCBP is in the process of obtaining her
Related Questions
- How does the elimination of the 23-day lockout for Female Patients of Childbearing Potential affect pharmacy requirements to obtain prescription authorizations?
- Has the 23-day lockout requirement been eliminated for Female Patients Not of Childbearing Potential and Male Patients?
- Has the 23-day lockout requirement been eliminated for Female Patients of Childbearing Potential?
